USP13 and ovarian carcinoma: Recently, in a novel ovarian cancer mouse model, overexpression of USP13 with deletion of PTEN and Trp53 (two important tumor suppressors) significantly enhanced the tumorigenic and metastatic properties of ovarian cancer (Kwon et al., 2022).